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CASE REPORT Open Access
Mechanical Thrombectomy of COVID-19
positive acute ischemic stroke patient: a
case report and call for preparedness
Ossama Yassin Mansour1* , Amer M. Malik2 and Italo Linfante3
Abstract
Background: The novel coronavirus (COVID-19) global pandemic is associated with an increased incidence of acute
ischemic stroke (AIS) secondary to large vessel occlusion (LVO). The treatment of these patients poses unique and
significant challenges to health care providers requiring changes in existing protocols.
Case presentation: A 54-year-old COVID-19 positive patient developed sudden onset left hemiparesis secondary to
an acute right middle cerebral artery occlusion (National Institutes of Health Stroke Scale (NIHSS) score = 11).
Mechanical thrombectomy (MT) was performed under a new protocol specifically designed to maximize protective
measures for the team involved in the care of the patient. Mechanical Thrombectomy was performed successfully
under general anesthesia resulting in TICI 3 recanalization. With regards to time metrics, time from door to
reperfusion was 60 mins. The 24-h NIHSS score decreased to 2. Patient was discharged after 19 days after
improvement of her pulmonary status with modified Rankin Scale = 1.
Conclusion: Patients infected by COVID-19 can develop LVO that is multifactorial in etiology. Mechanical
thrombectomy in a COVID-19 confirmed patient presenting with AIS due to LVO is feasible with current mechanical
thrombectomy devices. A change in stroke workflow and protocols is now necessary in order to deliver the
appropriate life-saving therapy for COVID-19 positive patients while protecting medical providers.
Keywords: Acute ischemic stroke, Mechanical thrombectomy, COVID-19, Coronavirus, SARS-CoV-2, Stroke workflow,
Personal protective equipment, Large vessel occlusion
Background
The first case of SARS-CoV-2 infection in Wuhan
Province of China in December 2019 [1]. As of 29 Feb.
2020, the number of laboratory-confirmed COVID-19
cases has exceeded 500,000 cases globally [2]. The clinical
presentation of COVID-19 patients varies considerably,
ranging from asymptomatic infection to severe pneumonia
that may lead to respiratory failure and death [3]. Recently,
Li et al. performed a meta-analysis of six studies reporting
data on COVID-19 patients. The authors reported the
presence of cardiac and cerebrovascular diseases in16.4%
of this population. In addition, they reported that the
incidence of vascular disease was three-fold higher among
severe COVID-19 patients requiring ICU care [4] In
addition, Li YaB et al. reported that 13 of 221 (5.8%) of the
cases who suffered from a SARS-CoV-2 infection devel-
oped acute cerebrovascular disease (CVD), possibly related
to the prothrombotic effect of the host inflammatory
response to the virus. Older patients with comorbidities
such as diabetes, pulmonary diseases and hypertension
are more likely to develop acute CVD. In addition, the
development of CVD in these patients is a significant
negative prognostic factor for survival and recovery
from COVID-19 infections [5]. Therefore, acute CVD is
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not uncommon in COVID-19 and is a significant risk
factor for mortality in these patients.
Multiple controlled randomized clinical trials have
demonstrated overwhelming superiority of mechanical
thrombectomy (MT) compared to medical management
in AIS secondary to large vessel occlusion (LVO) [6].
However, performing MT in patient with COVID 19 poses
significant health risk in health care providers and requires
changes in existing protocols. We report a clinical case of a
COVID-19 positive patient presenting to our center with
AIS secondary to LVO, treated successfully by MT. We
also describe the possible modifications for measures and
workflow to deliver appropriate treatment for such patients
in the era of the COVID-19 global pandemic.
Case presentation
A 54-year-old Italian patient was diagnosed and con-
firmed to be COVID-19 positive by Real Time quantita-
tive Reverse transcription polymerase chain reaction
RT-qPCR test performed with throat swabs. Six days
after the diagnosis, she developed sudden onset of left
hemiparesis and neglect. Patient was transferred emergently
via ambulance from a COVID-19 isolation hospital to
Alexandria University Affiliated Hospital where patient
arrived approximately 4.5 h after symptom onset. Continu-
ous communication with the ambulance team occurred,
including recommendation for intubation of the patient in
order to minimize in-hospital droplet and contact precau-
tions to shorten door-to-needle time. The patient’s oxygen
saturation subsequently dropped below 90% in the ambu-
lance and intubation was performed emergently by ambu-
lance team. Upon hospital arrival, she was admitted via an
isolated and guarded entrance specifically designed for: i)
patients with symptoms suspicious for COVID-19 and/or;
ii) diagnosed as being COVID-19 positive as per our
workflow AIS protocol (Fig. 1). In the emergency room,
evaluation indicated that the patient’s history was negative
for atrial fibrillation, hypertension, or diabetes. Neurological
examination revealed left lower facial palsy, hemiparesis,
hemisensory deficit, and right gaze deviation. The National
Institutes of Health Stroke Scale (NIHSS) = 11.
At admission, computed tomographic angiography
(CTA) and perfusion (CTP) imaging revealed acute right
MCAM1 occlusion with a large area of ischemic penumbra
Fig. 1 Proposed modified stroke protocol based on Egyptian MOH score system16 for suspecting patient for COVID-19
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(Fig. 2). Admission ABG and blood sample lab tests are
summarized in Table 1. Due to 4.5-h time delay from
symptom onset to presentation to our ED, the patient was
excluded to receive intravenous tissue plasminogen activa-
tor (IV tPA) according to current guidelines. Written
informed consent for mechanical thrombectomy (MT)
was obtained from the patient’s family through video
conference (according to hospital protocol for consent
taking for patients with AIS). The endovascular procedure
was performed with a transfemoral approach under
general anesthesia (GA).
The neuroendovascular team prepared the patient for
the procedure, under a pre-determined special personal
protective equipment (PPE) protocol for the care of
COVID-19 patients. Cerebral angiography revealed
occlusion of the right MCA (Fig. 3a). Mechanical thromb-
ectomy was performed according to current protocols.
Briefly, after obtaining access via the right femoral artery,
an 8-Fr guiding catheter (Guider softip XF; Stryker Neuro-
vascular, Fremont, CA, USA) was advanced into the right
internal carotid artery. A 6-Fr intermediate catheter (CAT™
6 Distal Access Catheter; Stryker Neurovascular, Fremont,
CA, USA) was navigated over a micro guidewire into the
occlusion site in the MCA (Fig. 3b). A direct aspiration first
pass technique (ADAPT) technique was performed via the
CAT 6 resulting in first-pass successful recanalization with
Thrombolysis in Cerebral Infarction (TICI) grade 3 recana-
lization. Symptom onset to reperfusion was 330min, door
to reperfusion time was 60min and groin-to-reperfusion
time was 22min (Fig. 3c). The thrombus extracted was
sent for histological examination (Fig. 3d). No procedure-
related complications occurred. After procedure comple-
tion, the patient was transferred back to the specialized
COVID-19 hospital and managed in the ICU. The patient’s
left hemiparesis improved the day after the MT procedure.
After extubation, her NIHSS score was = 2.
Mechanical Thrombectomy personal protective measures
Per our protocol for the care of COVID-19 patients, she
was transported to the angiography suite already intubated
to avoid exposure to the staff. During the procedure the
number of healthcare workers in the angiography suite was
minimized to operator, nurse, and a single anesthesiology
attending. Medical staff members received their personal
protective equipment (PPE) first. The PPE was packed in a
special box labeled ‘COVID-19’ and included the following:
yellow gown, gloves, visor, mask, surgical hoods, and
scrubs. Removal of all personal equipment before entering
the angiography suite was mandatory.
Briefly, the protocol started by wearing boots by
slipping the feet into them without touching before
proceeding to the scrubbing area. The next step involved
putting on protective leads that are classified as “dirty”
and restored for such cases. Next hand washing was
followed by placement of PPE head gear which included
a surgical hood followed by cap, mask, and visor. Place-
ment of this PPE was followed by placement of an N95
mask. Again, hands were washed before putting on the
yellow gown with the help of another member in the
angiography suite. For operators only, the next step was
Fig. 2 CTP & CTA of the patient showing acute right M1 occlusion (arrow) with large area of ischemic penumbra
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to scrub as they would normally do, except they com-
pleted this task with gloves and yellow gown on. For
non-operators, they wore the gloves included in the
COVID-19 box but they did not wear sterile gloves.
Once all of the PPE was on, the team proceeded to the
angiography suite for the intervention.
After the procedure was concluded, the patient was
safely transferred by ambulance to the original transfer-
ring hospital for further management. At this point,
members of the team began to take off their respective
PPE. The visor was removed first due to potential con-
tamination with blood or other fluids and disposed of in
a specially labeled bin. Subsequently, the sterile gloves
were taken off and disposed of in the same bin. The
gown was removed by tearing the ties and taking it off
by rolling on the inside and the gown was disposed of in
the bin. The last pair of gloves were removed and dis-
posed of in the bin. Then bin trash and its contents were
treated according the regulations recommended by local
health authority.
Discussion and conclusion
This is a report of a COVID 19 patient with AIS second-
ary due to LVO that underwent successful MT with
excellent clinical and angiographic outcome in contrary
to majority of reported case prognosis [7]. Patients with
COVID-19 infection, and in particular those requiring
ICU care, are more at risk to develop CVD and stroke4.
The acute management of COVID-19 patients with a
stroke is challenging because it requires specific proto-
cols to minimize exposure to the operators and staff
involved in the care of the patient in the angiography
suite. Current CDC guidelines have been previously pub-
lished and were followed in this case. Mechanical
thrombectomy is standard of care for AIS secondary to
LVO [8, 9]. Modification of the mechanical thrombec-
tomy workflow of LVO AIS patients should be consid-
ered to ensure the safety of the medical team and the
ongoing availability of the service with readiness of the
receiving hospital to handle patients during such difficult
times without disturbing existing pathways.
Another group of patients that could be included in
such protocols are those patients under investigation
(PUI) who are not yet confirmed to be COVID-19
positive status and still they are potentially infectious
[10]. In this group of PUI patients who present with
AIS, some protective measures during the pandemic
time should not waste the precious time necessary to
receive AIS reperfusion therapy. This goal relies on the
importance of having a protocol to deal with both sub-
groups of AIS in relation to COVID-19 infection (Fig. 1).
There is little data regarding acute CVD following
COVID-19 infection [5]. Inflammation has been increas-
ingly recognized as a key contributor to the pathophysi-
ology of cerebrovascular diseases [11]. In particular in LVO,
Fig. 3 a: Digital subtraction angiography showing right M1 occlusion. b: Reperfusion catheter navigated to occlusion site. c First pass TICI 3
recanalization. d Thrombus at the tip of the reperfusion catheter
Table 1 Laboratory investigation on admission of the COVID-19
positive patient presenting with acute ischemic stroke










Platelet count, 109/L 190
WBC, 109/L 8
Lymphocyte count, 109/L 0.4
CRP 21
PCT 12
ABG arterial blood gas, ALT alanine aminotransferase, CRP c-reactive protein,
PCT procalcitonin, PCO2 partial pressure of carbon dioxide, PO2 partial
pressure of oxygen, SaO2 oxygen saturation, WBC white blood count
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the inflammatory response may trigger events in the coagu-
lation cascade intravascularly [12, 13]. This seems to be the
case in our patients. In the patient described in this report,
there may have been increase in the inflammatory response
(elevated C-reactive protein and PCT in Table 1) and
abnormal blood coagulation function (elevated D-dimer in
Table 1) in the early stage which could be one of the main
reasons of acute onset CVD cited in a prior report [5]. In
addition, since respiratory infections and A-V mismatch
occur this may affect blood oxygenation putting penumbra
at risk, so these patients need aggressive medical manage-
ment of their underlying infection.
No defined data can confirm a causal relationship
between SARS-CoV-2 and ischemic stroke, since
competing vascular risk factors and mechanisms were
present in most of the reported patients. However, some
reports suggested that COVID-19 might stimulate the
production of antiphospholipid antibodies (aPL) [14] as
a mechanism of ischemic stroke, although postinfection
aPL are usually transient and unassociated with throm-
bosis. Nevertheless, our case suggests that stroke linked
to Covid-19 infection can occur in the context of a
systemic highly prothrombotic state, as no other vascular
risk was report in the current case.
With regards to changes in protocols and workflow,
undoubtedly COVID-19 frontline healthcare workers are
at a high risk for infection. Data from China’s National
Health Commission shows that more than 3300 health-
care workers have been infected as of early March 2020
and by the end of February at least 22 individuals had
died. In Italy, 20% of responding healthcare workers
were infected, and some have died. Reports from
medical staff describe physical and mental exhaustion,
the torment of difficulty with triage decisions, and the
pain of losing patients and colleagues, all in addition to
the active infection risk [15]. Therefore, the proper use
of PPE and following recommended protocols are key to
guaranteeing the safety of healthcare workers and are
essential to run any acute treatment workflow like that
employed for AIS [16].
Intubating such patients in the angiography suite could
lead to increasing the exposure to the medical team in the
stroke facility. Different protocols could be implemented to
decrease such exposure in our case. We recommend intub-
ating the patient before transfer to treating hospital or
angiography suite in negative pressure-controlled room in
ED or ICU that already had all PPE needed to deal with
such cases following COVID-19 protocols. Other protocols
for decreasing exposure during intubation may be used like
intubating in a negative pressure emergency department
room or under cover with video glidescope to avoid direct
exposure to the patient’s droplets. Additionally, the
use of telemedicine in diagnosis and administration of
IV thrombolysis may provide the ‘social distancing’ in
stroke practice that could decrease the infection exposure
of healthcare workers and should be considered in an AIS
management protocol modified to accommodate the recent
COVID-19 situation worldwide. Mechanical thrombectomy
was done under GA. Caution should be taken as these
patients are more prone to acute respiratory distress syn-
drome (ARDS) and recommendations for hemodynamics,
pulmonary function, and anesthesia drug selection should
be considered as in published guidelines. Patients with
COVID-19 infection are at increased risk of cerebrovascular
diseases and acute ischemic stroke. Mechanical thrombec-
tomy in AIS secondary to LVO in COVID-19 patients is
feasible. However, existing stroke protocols should be
modified following CDC guidelines for PUI or confirmed
COVID-19 cases to deliver effective care for these patients
and protect healthcare workers in this field.
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